The Patent Finder

Aprogen Medicines Inc.

Also on record
Records under this name other than patents Aprogen Medicines Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Aprogen Medicines Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,259,860Fusion Proteins Binding to VEGF and Angiopoietin
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,246,517Antibody Binding to Carbonic Anhydrase and Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,676,531Anti-CD43 antibody and use thereof for cancer treatment
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,975,160Antibody binding to carbonic anhydrase and use thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,542,339Anti-CD43 antibody and use thereof for cancer treatment
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,820,831Antibody Binding to Carbonic Anhydrase and Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,192,959Antibody Binding to Carbonic Anhydrase and Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,691,366Chimeric CMP-Ang1 molecule
Formerly held
Term ended
Term ended Oct 18, 2022 · USPTO record
Term endedTerm ended Oct 18, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited